316 related articles for article (PubMed ID: 22132920)
1. Progression of cerebrospinal fluid cell count and differential over a treatment course of shunt infection.
Fulkerson DH; Sivaganesan A; Hill JD; Edwards JR; Shoja MM; Boaz JC; Jea A
J Neurosurg Pediatr; 2011 Dec; 8(6):613-9. PubMed ID: 22132920
[TBL] [Abstract][Full Text] [Related]
2. Characteristics and treatment outcome of cerebrospinal fluid shunt-associated infections in adults: a retrospective analysis over an 11-year period.
Conen A; Walti LN; Merlo A; Fluckiger U; Battegay M; Trampuz A
Clin Infect Dis; 2008 Jul; 47(1):73-82. PubMed ID: 18484878
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid eosinophilia in children with ventricular shunts.
Fulkerson DH; Boaz JC
J Neurosurg Pediatr; 2008 Apr; 1(4):288-95. PubMed ID: 18377304
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid shunt infections in children over a 13-year period: anaerobic cultures and comparison of clinical signs of infection with Propionibacterium acnes and with other bacteria.
Arnell K; Cesarini K; Lagerqvist-Widh A; Wester T; Sjölin J
J Neurosurg Pediatr; 2008 May; 1(5):366-72. PubMed ID: 18447670
[TBL] [Abstract][Full Text] [Related]
5. Effect of antibiotic-impregnated shunt catheters in decreasing the incidence of shunt infection in the treatment of hydrocephalus.
Sciubba DM; Stuart RM; McGirt MJ; Woodworth GF; Samdani A; Carson B; Jallo GI
J Neurosurg; 2005 Aug; 103(2 Suppl):131-6. PubMed ID: 16370278
[TBL] [Abstract][Full Text] [Related]
6. Do antibiotic-impregnated shunts in hydrocephalus therapy reduce the risk of infection? An observational study in 258 patients.
Ritz R; Roser F; Morgalla M; Dietz K; Tatagiba M; Will BE
BMC Infect Dis; 2007 May; 7():38. PubMed ID: 17488498
[TBL] [Abstract][Full Text] [Related]
7. Management of shunt infections: a multicenter pilot study.
Kestle JR; Garton HJ; Whitehead WE; Drake JM; Kulkarni AV; Cochrane DD; Muszynski C; Walker ML
J Neurosurg; 2006 Sep; 105(3 Suppl):177-81. PubMed ID: 16970229
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the risk of shunt failure or infection related to cerebrospinal fluid cell count, protein level, and glucose levels in low-birth-weight premature infants with posthemorrhagic hydrocephalus.
Fulkerson DH; Vachhrajani S; Bohnstedt BN; Patel NB; Patel AJ; Fox BD; Jea A; Boaz JC
J Neurosurg Pediatr; 2011 Feb; 7(2):147-51. PubMed ID: 21284459
[TBL] [Abstract][Full Text] [Related]
9. Management of complicated shunt infections: a clinical report.
James HE; Bradley JS
J Neurosurg Pediatr; 2008 Mar; 1(3):223-8. PubMed ID: 18352767
[TBL] [Abstract][Full Text] [Related]
10. Conservative management of patients with cerebrospinal fluid shunt infections.
Brown EM; Edwards RJ; Pople IK
Neurosurgery; 2006 Apr; 58(4):657-65; discussion 657-65. PubMed ID: 16575329
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic-impregnated shunt systems versus standard shunt systems: a meta- and cost-savings analysis.
Klimo P; Thompson CJ; Ragel BT; Boop FA
J Neurosurg Pediatr; 2011 Dec; 8(6):600-12. PubMed ID: 22132919
[TBL] [Abstract][Full Text] [Related]
12. Hospital costs associated with shunt infections in patients receiving antibiotic-impregnated shunt catheters versus standard shunt catheters.
Attenello FJ; Garces-Ambrossi GL; Zaidi HA; Sciubba DM; Jallo GI
Neurosurgery; 2010 Feb; 66(2):284-9; discussion 289. PubMed ID: 20087127
[TBL] [Abstract][Full Text] [Related]
13. Treatment of cerebrospinal fluid shunt infections in children using systemic and intraventricular antibiotic therapy in combination with externalization of the ventricular catheter: efficacy in 34 consecutively treated infections.
Arnell K; Enblad P; Wester T; Sjölin J
J Neurosurg; 2007 Sep; 107(3 Suppl):213-9. PubMed ID: 17918527
[TBL] [Abstract][Full Text] [Related]
14. Aggressive management of shunt infection: combined intravenous and intraventricular antibiotic therapy for twelve or less days.
James HE; Bradley JS
Pediatr Neurosurg; 2008; 44(2):104-11. PubMed ID: 18230923
[TBL] [Abstract][Full Text] [Related]
15. Effect of antibiotic-impregnated shunts on infection rate in adult hydrocephalus: a single institution's experience.
Farber SH; Parker SL; Adogwa O; McGirt MJ; Rigamonti D
Neurosurgery; 2011 Sep; 69(3):625-9; discussion 629. PubMed ID: 21499157
[TBL] [Abstract][Full Text] [Related]
16. The value of C-reactive protein in the management of shunt infections.
Schuhmann MU; Ostrowski KR; Draper EJ; Chu JW; Ham SD; Sood S; McAllister JP
J Neurosurg; 2005 Sep; 103(3 Suppl):223-30. PubMed ID: 16238075
[TBL] [Abstract][Full Text] [Related]
17. Reduction in shunt infection using antibiotic impregnated CSF shunt catheters: an Australian prospective study.
Pattavilakom A; Xenos C; Bradfield O; Danks RA
J Clin Neurosci; 2007 Jun; 14(6):526-31. PubMed ID: 17430776
[TBL] [Abstract][Full Text] [Related]
18. Clinical and economic consequences of antibiotic-impregnated cerebrospinal fluid shunt catheters.
Eymann R; Chehab S; Strowitzki M; Steudel WI; Kiefer M
J Neurosurg Pediatr; 2008 Jun; 1(6):444-50. PubMed ID: 18518694
[TBL] [Abstract][Full Text] [Related]
19. Linezolid treatment of shunt-related cerebrospinal fluid infections in children.
Yilmaz A; Dalgic N; Müslüman M; Sancar M; Colak I; Aydin Y
J Neurosurg Pediatr; 2010 May; 5(5):443-8. PubMed ID: 20433254
[TBL] [Abstract][Full Text] [Related]
20. How long should cerebrospinal fluid cultures be held to detect shunt infections? Clinical article.
Desai A; Lollis SS; Missios S; Radwan T; Zuaro DE; Schwarzman JD; Duhaime AC
J Neurosurg Pediatr; 2009 Aug; 4(2):184-9. PubMed ID: 19645555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
